IL17A and lobular neoplasia: In relation to response to treatment, in a study involving 52 patients with active LN (who underwent kidney biopsy at baseline and after immunosuppressive therapy), higher IL-17 levels at baseline were associated with persisting active nephritis after treatment (WHO III, IV, V) (42).